Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
about
Elevated serum levels of immunoglobulin A correlate with the possibility of readmission in patients with microscopic polyangiitis.Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis.Diagnosing ANCA-associated vasculitis in ANCA positive patients: A retrospective analysis on the role of clinical symptoms and the ANCA titre.Predictive factors for mortality in elderly Japanese patients with severe microscopic polyangiitis: A retrospective single-center study.Treating elderly patients with ANCA-associated vasculitis
P2860
Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
@ast
Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
@en
type
label
Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
@ast
Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
@en
prefLabel
Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
@ast
Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
@en
P2093
P2860
P1476
Rituximab for remission induction in elderly patients with ANCA-associated vasculitis
@en
P2093
P2860
P356
10.1016/J.SEMARTHRIT.2015.02.005
P50
P577
2015-02-20T00:00:00Z